Menu

Alto Neuroscience, Inc. ANRO

Full chart Compare
Set alert

Price alert · ANRO

All alert types
25.16 USD +3.29 (+15.04%)

At closeNov 6, 2026, 6:25 PM EST

25.03 -0.13 -0.52%

After hours · Nov 6, 6:25 PM ET

21.96 Day range 25.42
11.13 52-week range 36.64
YTD
+41.35%
1 year
+126.06%

Revenue & Expenses

Other Income → Expenses: $2.87MExpenses → Selling, General & Admin: $3.75MExpenses → Research & Development: $8.37MGross Profit → Expenses: $65.00KRevenue → Gross Profit: $65.00KRevenue → Cost of Revenue: $145.00KNet Loss → Expenses: $9.19MOther Income$2.87MGross Profit$65.00KNet Loss$9.19MCost of Revenue$145.00KExpenses$12.12MSelling, General & Admin$3.75MResearch & Development$8.37MRevenue$210.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

ANRO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-66.36M-68.61M-37.81M-29.19M-12.06M
-63.24M-61.43M-36.30M-27.71M-9.19M
-2.19-2.50-9.73-8.04-1.71
ANRO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
176.98M168.73M82.55M48.34M25.70M
184.69M177.54M86.63M50.85M28.79M
33.55M26.08M16.82M17.02M3.11M
22.81M16.07M9.86M9.46M0
151.14M151.46M-71.67M-38.41M-12.48M
ANRO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-51.77M-47.42M-33.45M-20.39M-9.26M
-24.00K-2.08M-470.00K-732.00K-680.00K
60.08M135.69M68.13M43.79M31.69M
-24.00K-2.08M-470.00K-732.00K-680.00K
8.26M86.18M34.20M22.64M21.70M